The federal hammer finally came down on the woman the Los Angeles underworld knew as the Ketamine Queen. Jasveen Sangha was sentenced to 15 years in federal prison for her role in the drug distribution network that killed Matthew Perry. It’s a massive moment for a legal system often accused of letting celebrity-adjacent dealers slide. This wasn’t just a simple drug bust. It was a targeted dismantling of a high-end supply chain that treated human lives like inventory numbers.
If you followed the initial headlines, you know the basics. Perry died from the acute effects of ketamine in October 2023. But the real story is about what happens behind the closed doors of North Hollywood boutiques and luxury condos. Sangha didn't just sell drugs. She ran a sophisticated "drug-selling emporium" that catered to a wealthy, vulnerable clientele. The sentencing reflects a shift in how the Department of Justice handles overdose deaths linked to professional distributors.
Why the Ketamine Queen got 15 years
Fifteen years feels like a lifetime. In the context of federal sentencing guidelines, it's a loud message. The judge wasn't just looking at a single transaction. Prosecutors painted a picture of a woman who knew exactly what she was doing. They showed she continued to sell her "high-quality" stash even after she knew her product was killing people.
Evidence presented during the case showed Sangha’s callousness. After learning about Perry’s death through news reports, she didn't call for help or express remorse. She searched for ways to delete her digital footprint. She tried to wipe the evidence. That kind of behavior makes it very hard for a defense attorney to argue for leniency. The court saw a predator, not a victim of circumstance.
The sentencing isn't just about Perry. It's about a broader crackdown on the illegal distribution of ketamine. While the drug has legitimate medical uses for depression and pain management when supervised by professionals, the street version is a different beast. Sangha was moving volume that rivaled mid-level cartels, all from her stylish home.
The dangerous myth of safe Hollywood drug use
There’s this weird idea that if you buy drugs in a nice neighborhood from someone in a designer outfit, it’s somehow safer. It’s not. The Matthew Perry case exposed the "broker" system in Los Angeles. This system relies on a network of enablers, doctors, and dealers who prioritize profit over safety.
In this case, we saw a horrific synergy between a licensed physician and a street dealer. Dr. Salvador Plasencia allegedly worked with Sangha to supply Perry with the ketamine that eventually took his life. When a doctor starts acting like a back-alley dealer, the guardrails are gone. They saw Perry’s addiction as a "payday" rather than a medical crisis.
People think ketamine is a "soft" drug because it's used in hospitals. That’s a mistake. In a clinical setting, your vitals are monitored. In a hot tub in Pacific Palisades, it’s a death trap. The dosage Perry was receiving was enough to put a surgical patient under. Without a ventilator and a team of nurses, that’s a one-way trip.
Lessons from the Perry investigation
The DEA and local police used every tool in the shed for this one. They went through thousands of encrypted messages. They tracked the money. They flipped smaller players to get to the "Queen."
- Digital footprints are permanent. Sangha thought she was safe using encrypted apps, but investigators found the breadcrumbs.
- Enablers face the music too. The charges against Perry’s live-in assistant, Kenneth Iwamasa, showed that even those who don't sell the drugs can be held responsible for administering them.
- The "Queen" label backfired. Bragging about your status in the drug world makes for a great prosecution narrative.
The defense tried to argue that Sangha was being scapegoated because of Perry’s fame. They weren't entirely wrong about the attention, but the evidence was too heavy. You don't get 15 years just for being famous-adjacent. You get it for running a business that kills your customers and then trying to cover your tracks.
What this means for the future of drug enforcement
Expect more of this. The feds are increasingly using "death resulting" statutes to go after dealers. It doesn't matter if you're a kid on a corner or a socialite in a condo. If your product kills someone, they’re coming for your house and your freedom.
The Perry case changed the math for high-end dealers in LA. The risk-to-reward ratio just shifted dramatically. For years, these types of operations flew under the radar because they didn't involve street violence or visible gang activity. Now, the body count is the only metric that matters.
If you’re watching this from the sidelines, don't think it’s just a celebrity drama. It’s a cautionary tale about the intersection of wealth, addiction, and the dark side of the wellness industry. Ketamine is being marketed as a miracle cure, but in the wrong hands, it’s just another way to die.
Keep an eye on the remaining defendants in this case. The doctors involved are still facing significant legal hurdles. Their medical licenses are the least of their worries. They’re looking at decades behind bars. The message is clear. The party's over for the Hollywood enablers.
Check your local news for updates on the Dr. Plasencia trial. It’s going to reveal even more about how these "boutique" drug rings operate. Stay informed about the risks of off-label drug use. Don't trust a "source" just because they live in a zip code you recognize.
